CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
Enregistré dans:
Auteurs principaux: | Leonardo M. R. Ferreira, Yannick D. Muller |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/90c7b03593cf43948e37aab8ab55cd77 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells
par: Arthur Bister, et autres
Publié: (2021) -
Quantification of cell-free DNAfor the analysis of CD19-CAR-T cells during lymphoma treatment
par: Thomas Mika, et autres
Publié: (2021) -
Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
par: Cristina Aparicio, et autres
Publié: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
par: Christopher Sloas, et autres
Publié: (2021) -
How Can We Engineer CAR T Cells to Overcome Resistance?
par: Glover M, et autres
Publié: (2021)